From: Sublingual sugar for hypoglycaemia in children with severe malaria: A pilot clinical study
Sublingual Sugar (SLS) n = 14 (95%CI) | Intravenous Glucose (IVG) n = 9 (95%CI) | |
---|---|---|
Sex (% F) | 29 | 44 |
Mean age (months) | 26.7 (19.8–33.7) | 34.3 (5.8–62.8) |
Mean weight (kg) | 10.8 (9.4–12.7) | 10.1 (6.9–13.1) |
Duration of illness before presentation (days) | 2.55 (1.4–4.1) | 2.79 (1.8–3.1) |
Coma£ | 2 (14%) | 5 (56%) |
Prostration (%) | 12 (86%) | 7 (78%) |
Convulsions (%) | 3 (21%) | 1 (11%) |
Respiratory distress (%) | 7 (50%) | 5 (56%) |
Splenomegaly (%) | 4 (29%) | 4 (44%) |
Malnutrition (%)* | 1 (7%) | 0 |
Mean temperature °C | 38.9 (38.3–39.3) | 38.3 (37.2–39.3) |
Mean glycaemia (mg/dl) | 46.5 (40.7–52.2) | 45.0 (36.0–53.9) |
Number of children with BGC < 40 mg/dl (< 2.2 mmol/l) | 3 (21%) | 2 (22%) |
Number of children with BGC < 54 mg/dl (< 3.0 mml/L) | 10 (71%) | 6 (79%) |
Thick film positive for P. falciparum (%) | 11 (79%) | 8 (89%) |